# Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study

> **NCT00493428** · PHASE2 · WITHDRAWN · sponsor: **University of Manitoba**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Baclofen

## Key facts

- **NCT ID:** NCT00493428
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study have been stoped because the protocol is going to be modify.
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493428, "Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00493428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*